Literature DB >> 2256479

Blood pressure in minimal change and other types of nephrotic syndrome.

S Küster1, O Mehls, C Seidel, E Ritz.   

Abstract

Blood pressure was evaluated in adult patients (n = 9) and children (n = 57) with nephrotic syndrome and minimal change glomerulonephritis (GN). Prior to steroid treatment in the edematous phase, hypertension was found in 78% of adults (BP greater than or equal to 140/90 mm Hg or antihypertensive treatment other than diuretics) and 95% of children (BP greater than 95 percentile of age). After complete remission, the prevalence of hypertension decreased to 33% in adults and 19% in children. In 21 children with early focal segmental glomerulosclerosis, the prevalence of hypertension (BP greater than 95th percentile) was 91% and 24% after complete remission. In 20 adult patients with membranous GN, the prevalence of hypertension in the edematous phase was 89% and 30% after complete or partial remission. It is concluded that, irrespective of age, hypertension is a common feature of the nephrotic syndrome unrelated to steroid therapy or renal failure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2256479     DOI: 10.1159/000168198

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

1.  Ambulatory Blood Pressure Monitoring in Frequently Relapsing Nephrotic Syndrome.

Authors:  Subhankar Sarkar; Aditi Sinha; Ramakrishnan Lakshmy; Anuja Agarwala; Anita Saxena; Pankaj Hari; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2016-08-19       Impact factor: 1.967

2.  Hypertension and its severity in children with steroid sensitive nephrotic syndrome during remission.

Authors:  Swasti Keshri; Shobha Sharma; Neha Agrawal; Sandeep Bansal; B P Guilliani; Kailash Chandra Aggrawal
Journal:  Clin Exp Nephrol       Date:  2018-03-22       Impact factor: 2.801

Review 3.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.

Authors:  Agnes Trautmann; Olivia Boyer; Elisabeth Hodson; Arvind Bagga; Debbie S Gipson; Susan Samuel; Jack Wetzels; Khalid Alhasan; Sushmita Banerjee; Rajendra Bhimma; Melvin Bonilla-Felix; Francisco Cano; Martin Christian; Deirdre Hahn; Hee Gyung Kang; Koichi Nakanishi; Hesham Safouh; Howard Trachtman; Hong Xu; Wendy Cook; Marina Vivarelli; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2022-10-21       Impact factor: 3.651

Review 4.  Nephroprotective effect of ACE inhibitors.

Authors:  S Orth; M Nowicki; A Wiecek; E Ritz
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 5.  The non-immunosuppressive management of childhood nephrotic syndrome.

Authors:  James McCaffrey; Rachel Lennon; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2015-11-10       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.